Redx Pharma signs $880m deal with Nasdaq-listed Jazz Pharmaceuticals
Redx is eligible to receive up to $870m in development, regulatory and commercial milestone payments from Jazz.
Source: cityam.com
Robert Iannone News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robert Iannone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robert Iannone Today - Breaking & Trending Today
Jazz hands at RedX as deal signed to licence drugs that could be worth $870m
Lisa Anson says partnerships remain key pillar of RedX corporate strategy
Source: thebusinessdesk.com
Jazz Pharma In Deal To Buy Redx Pharma's KRAS Inhibitor Program; Redx Stock Up
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) Wednesday said it has signed a definitive agreement to acquire Redx Pharma plc's (REDX.L) proprietary ...
Source: businessinsider.com
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Krista, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2023 Earnings Call.
Source: insidermonkey.com
European Commission Approves Rylaze for ALL and Lymphoblastic Lymphoma
The European Commission has granted marketing authorization for Rylaze for use as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 month and older who developed hypersensitivity or silent inactivation to E. coli–derived asparaginase.
Source: onclive.com